Personalis In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More News items for the week of Jan. 3, 2023. Losses Deep and Widespread as GenomeWeb Top 40 Drops 34 Percent in 2022 All but two Top 40 companies declined, with over half losing more than 50 percent of their value and 13 companies losing three-quarters of their value or more. People in the News at Personalis, Roche, Massive Bio, SeqLL, More Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Dec. 12, 2022. Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring Researchers will employ the company's tumor-informed, personalized assays to analyze ctDNA patterns linked to immunotherapy drug response. People in the News at Pacific Biosciences, Personalis, Epic Sciences, Cytek Biosciences, More Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 31, 2022. Nov 3, 2022 Personalis Q3 Revenues Down 33 Percent on Disputed VA Contract Oct 4, 2022 Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer Sep 7, 2022 Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain Premium Aug 18, 2022 Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit Aug 15, 2022 Personalis, BC Cancer Partner on Study of ctDNA MRD Tests for Colorectal, Pancreatic Cancers Aug 5, 2022 Earnings Roundup: Waters, Personalis, Opko Health, Biodesix, Exagen Aug 2, 2022 Personalis Sues Foresight Diagnostics, Alleging Patent Infringement May 6, 2022 Personalis Building Data for High-Sensitivity Residual Cancer Assay Premium May 4, 2022 Personalis Q1 Revenues Drop 27 Percent Apr 26, 2022 Evaxion Biotech Adopts Personalis Immune Profiling Platform for Melanoma Immunotherapy Trial Feb 28, 2022 Personalis Locks in Clinical Launch Plans as Oncology Testing Takes Lead Over Population Sequencing Premium Feb 24, 2022 Personalis Q4 Revenues Bump up 3 Percent Feb 15, 2022 Personalis, UCSD Cancer Center Ink Clinical Genomic Testing, Research Partnership Jan 7, 2022 Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent Jan 4, 2022 Fulgent Genetics, Bio-Techne Lead Winners as GenomeWeb Index Gains 12 Percent in 2021 Jan 3, 2022 Personalis Signs Deal With BTIG for $100M At-Market Stock Offering Dec 17, 2021 New Products Posted to GenomeWeb: Thermo Fisher, Personalis, Menarini Silicon Biosystems, More Nov 4, 2021 Personalis Q3 Revenues Climb 12 Percent Oct 15, 2021 People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More Oct 13, 2021 Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.